Search by Drug Name or NDC

    NDC 47335-0943-18 Lacosamide 150 mg/1 Details

    Lacosamide 150 mg/1

    Lacosamide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is LACOSAMIDE.

    Product Information

    NDC 47335-0943
    Product ID 47335-943_4bfda9bf-5a78-47a6-9d71-48f3a080dc7e
    Associated GPIs 72600036000340
    GCN Sequence Number 064434
    GCN Sequence Number Description lacosamide TABLET 150 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14341
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name Lacosamide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lacosamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name LACOSAMIDE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA205031
    Listing Certified Through 2024-12-31

    Package

    NDC 47335-0943-18 (47335094318)

    NDC Package Code 47335-943-18
    Billing NDC 47335094318
    Package 1000 TABLET, FILM COATED in 1 BOTTLE (47335-943-18)
    Marketing Start Date 2022-03-19
    NDC Exclude Flag N
    Pricing Information N/A